Back to Treatments

Treatment

Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine)

1

Conditions

25

Trials

2,500

Participants

55%

Average Safety

Condition Evidence

Visceral leishmaniasis

25 trials · 2,500 participants

98% effectiveness · 55% safety

Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine) | DFDA